Dabigatran Etexilate

• MidregiOnal proatrial natriuretic peptide to guide SEcondary Stroke prevention: The MOSES-study Pending
  2024-517600-11-01 Phase III 2 countries Universitaetsspital Basel
• Anticoagulant medicines for Balloon Pulmonary Angioplasty Pending
  2024-518803-23-00 Phase IV 1 country St. Antonius Ziekenhuis
• Short-Term Anticoagulation versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure. The ANDES s… Pending
  2025-520954-12-00 Phase IV 1 country Centre Hospitalier Universite De Laval
• Preventing formation of blood clots due to atrial fibrillation, a cardiac arrhythmia that first occurred after coronary bypass surgery, with… Recruiting
  2024-515924-35-00 Phase IV 1 country Icahn School Of Medicine At Mount Sinai
• DANNOAC- The Danish Non-vitamin K Antagonist Oral Anticoagulation Study Ended
  2022-501912-32-00 Phase IV 1 country Bispebjerg Hospital; Gentofte Hospital
• The Nordic Aortic Valve Intervention Trial 4 (NOTION-4) Ended
  2024-518547-38-00 Phase IV 1 country Rigshospitalet
• Vitamin-K-Antagonist and direct thrombin inhibitor Dabigatran for thrombus resolution in left ventricular thrombus after acute STEMI (ST-ele… Ended
  2022-500383-35-00 Phase II 1 country Medical University Of Graz
• A study to learn how the study drug elinzanetant (BAY 3427080) affects the way the drug dabigatran moves into, through and out of the body i… Ended
  2022-500201-41-00 Phase I (Other) 1 country Bayer AG; Bayer Consumer Care AG

Showing 1–8 of 8 trials